Mikhail Naum Kosiborod
70PUBLICATIONS
254CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (70)
Sort by Publication Date:
|May 12, 2025
The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.Naveed Sattar, Govinda J Weerakkody, Darren K McGuire
|Dec 14, 2024
Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide.Subodh Verma, Francesco Cosentino, Mikhail N Kosiborod
|Nov 04, 2024
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2).Sean Wharton, Carel W le Roux, Mikhail N Kosiborod
|Oct 18, 2024
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction.Senthil Selvaraj, Shachi Patel, Andrew J Sauer
|Sep 03, 2024
Response by Kosiborod et al to Letter Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial".Mikhail N Kosiborod, Mark C Petrie, Barry A Borlaug
Pageof 12
Frequent Collaborators
19 joint publications
John J V McMurray
16 joint publications
Sanjiv J Shah
15 joint publications
Scott D Solomon
15 joint publications
Pardeep S Jhund
15 joint publications
Rudolf A de Boer
15 joint publications
Silvio E Inzucchi
11 joint publications
Carolyn S P Lam
10 joint publications
Felipe Martinez
9 joint publications
Subodh Verma
8 joint publications
Piotr Ponikowski